place after the MCR, are in turn able to rigidify the often
acyclic multicomponent adducts into a number of cyclic
species. As such, multicomponent approaches are ideal
to address some of the drawbacks affecting classical
heterocyclic syntheses, such as poor availability of
starting materials or the need for difficult, lengthy, and
elaborate synthetic operations.7 Our group has signifi-
cant experience in the design of novel chemotypes via
these kinds of pathways, as exemplified by reports deal-
ing with the preparation of quinoxalines, benzodiaze-
pines, benzimidazoles, pyrrolidinones, and pyrazoles,
inter alia.8
recent work,9 microwave irradiation at elevated tempera-
tures and 2 equiv of organic bases were employed to
trigger the cyclization step. Different temperatures, reac-
tion times, and solvents were next evaluated (Table 1),
and heating at 160 °C for 20 min in DMF in the presence
of diisopropylamine (DIPA, entry 2) proved optimal,
smoothly affording cyclized product 2a in a very satisfac-
tory 75% yield over two steps.
Table 1. Optimization of the Cyclization Step in the UgiÀAldol
Sequence
Inspired by our recent findings on the applicability of
aldol reactions to the development of domino sequences9
and with the intent of devising new straightforward one-
pot strategies to enrich the heterocyclic chemistry toolbox,
we embarked on a campaign to investigate the possibilities
suggested by this approach. Initially, we turned our attention
to the synthesis of the pyrrolinone moiety, a very appeal-
ing biological scaffold shown to be a key motif in HIV-1
integrase inhibitors,10 peptidomimetics,11 and marine natur-
al products possessing relevant antibacterial properties, such
as holomycine12 and tetramic acids.13
The assembly of the acyclic precursor for this chemotype
was accomplished by means of the Ugi four-component
condensation (U-4CR),14 which predictably performed
well under the classical mild conditions.15 Pyruvic alde-
hyde, n-butylisonitrile, 2,4-dichlorophenylacetic acid, and
benzylamine were mixed in methanol and stirred overnight
at room temperature. Upon formation of 1a, the solvent
was removed and the crude residue was subjected to the
aldol reaction without any purification. On the basis of our
temp
time
yield
(%)
entry
solvent
base
(°C)
(min)
1
2
3
4
5
6
DMF
DMF
DMF
DMF
DMSO
THF
DIPA
DIPA
DIPA
TEA
140
160
160
160
160
160
20
20
40
20
20
20
56
75
57
57
43
50
(7) For significant examples of this approach to the synthesis of
heterocycles, see: (a) Banfi, L.; Basso, A.; Guanti, G.; Kielland, N.;
Repetto, C.; Riva, R. J. Org. Chem. 2007, 72, 2151. (b) Wang, W.; Ollio,
€
S.; Herdtweck, E.; Domling, A. J. Org. Chem. 2011, 76, 637. (c) Znabet,
DIPA
DIPA
A.; Zonneveld, J.; Janssen, E.; De Kanter, F. J. J.; Helliwell, M.; Turner,
N. J.; Ruijter, E.; Orru, R. V. A. Chem. Commun. 2011, 46, 7706. (d) Erb,
W.; Neuville, L.; Zhu, J. J. Org. Chem. 2009, 74, 3109. (e) El Kaim, L.;
Gizolme, M.; Grimaud, L. Synlett 2007, 227. (f) De Moliner, F.;
Crosignani, S.; Galatini, A.; Riva, R.; Basso, A. ACS Comb. Sci.
2011, 13, 453.
(8) For example, see: (a) De Moliner, F.; Hulme, C. Org. Lett. 2012,
14, 1354. (b) De Moliner, F.; Hulme, C. Tetrahedron Lett. 2012, 53, 5787.
(c) Gunawan, S.; Ayaz, M.; De Moliner, F.; Frett, B.; Kaiser, C.;
Patrick, N.; Hulme, C. Tetrahedron 2012, 68, 5606. (d) Shaw, A. Y.;
Medda, F.; Hulme, C. Tetrahedron Lett. 2012, 53, 1313. (e) Xu, Z.; Ayaz,
M.; Cappelli, A. P.; Hulme, C. ACS Comb. Sci. 2012, 14, 460.
(f) Gunawan, S.; Petit, J.; Hulme, C. ACS Comb. Sci. 2012, 14, 160.
(g) Shaw, A. Y.; McLaren, J. A.; Nichols, G S.; Hulme, C. Tetrahedron
Lett. 2012, 53, 2592.
With optimized conditions for the second step of the
sequence in hand, we thus investigated the use of different
starting materials in order to determine the reactivity
domain of the UgiÀaldol two-step, one-pot route and to
assemble a small collection of compounds of generic
structure 2. Overall, two glyoxaldehydes, three isonitriles,
four carboxylic acids, and eight amines were employed to
build a representative set (Table 2) with yields of 2aÀ2i
spanning 62À82%, requiring only column chromatogra-
phy of the final product.
The advantages of the multicomponent approach to
the synthesis of 2 over conventional linear methodologies
are numerous. In fact, reported stepwise protocols for
the preparation of pyrrolinones mostly involve the use
of exotic starting materials, transition metal catalysts, and/
or lengthy multistep routes and suffer from a resulting lack
of generality and practical ease.16 The strategy described
herein also differs from the existing multicomponent pro-
tocols leading to this chemotype, which either are unable
to render final products with four diversity points17 or rely
(9) Xu, Z.; De Moliner, F.; Cappelli, A. P.; Hulme, C. Angew. Chem.,
Int. Ed. 2012, 51, 8037.
(10) (a) Pace, P.; Spieser, S. A. H.; Summa, V. Bioorg. Med. Chem.
Lett. 2008, 18, 3865. (b) Ma, K.; Wang, P.; Fu, W.; Wan, X.; Zhou, L.;
Chu, Y.; Ye, D. Bioorg. Med. Chem. Lett. 2011, 21, 6724.
(11) Raghuraman, A.; Ko, E.; Perez, L. M.; Ioerger, T. R.; Burgess,
K. J. Am. Chem. Soc. 2011, 133, 12350.
(12) (a) Wietz, M.; Mansson, M.; Gotfredsen, C. H.; Larsen, T. O.;
Gram, L. Mar. Drugs 2010, 8, 2946. (b) Hjelmgaard, T.; Givskov, M.;
Nielsen, J. Org. Biomol. Chem. 2007, 5, 344.
(13) (a) Ueda, C.; Tateda, K.; Horikawa, M.; Kimura, S.; Ishii, Y.;
Nomura, K.; Yamada, K.; Suematsu, T.; Inoue, Y.; Ishiguro, M.;
Miyairi, S.; Yamaguchi, K. Antimicrob. Agents Chemother. 2010, 54,
683. (b) Holloway, C. A.; Matthews, C. J.; Jeong, Y.-C.; Moloney,
M. G.; Roberts, C. F.; Yaqoob, M. Chem. Biol. Drug Des. 2011, 78, 229.
(14) Ugi, I.; Steinbruckner, C. Angew. Chem. 1960, 72, 267.
(15) Marcaccini, S.; Torroba, T. Nat. Protoc. 2007, 2, 632.
Org. Lett., Vol. 15, No. 11, 2013
2739